OncoTherapy Science [4564]: Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 [Japanese GAAP] (Consolidated), 6 November 2026 (Timely Disclosure): Nikkei Company Information DIGITAL

The story

OncoTherapy Science published its consolidated earnings summary under Japanese GAAP for the second quarter (interim period) of the fiscal year ending March 2027.

The announcement was made at 17:00 on 6 November 2026, and detailed information on the announcement materials is available through Nikkei Company Information DIGITAL.

At a glance

CompanyOncoTherapy Science

PeriodSecond quarter (interim period) of the fiscal year ending March 2027

NaturePublished consolidated earnings summary under Japanese GAAP

Date6 November 2026 17:00

SourceDetailed information is available through Nikkei Company Information DIGITAL

Reference information. Every claim resolves to something the story actually named.

Where this came from

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

google.comNews

AgreesOpen

Read the original articleGo to the source page

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.